Inflammation, immunological reaction and role of infection in pulmonary hypertension

Rubin, 2006, Pulmonary arterial hypertension, Proc Am Thorac Soc, 3, 111, 10.1513/pats.200510-112JH Simonneau, 2009, Updated clinical classification of pulmonary hypertension, J Am Coll Cardiol, 54, S43, 10.1016/j.jacc.2009.04.012 Budhiraja, 2004, Endothelial dysfunction in pulmonary hypertension, Circulation, 109, 159, 10.1161/01.CIR.0000102381.57477.50 Hassoun, 2009, Inflammation, growth factors, and pulmonary vascular remodeling, J Am Coll Cardiol, 54, S10, 10.1016/j.jacc.2009.04.006 Dorfmuller, 2003, Inflammation in pulmonary arterial hypertension, Eur Respir J, 22, 358, 10.1183/09031936.03.00038903 Libby, 2007, Inflammatory mechanisms: the molecular basis of inflammation and disease, Nutr Rev, 65, S140, 10.1301/nr.2007.dec.S140-S146 Medzhitov, 2008, Origin and physiological roles of inflammation, Nature, 454, 428, 10.1038/nature07201 Nicolls, 2005, Autoimmunity and pulmonary hypertension: a perspective, Eur Respir J, 26, 1110, 10.1183/09031936.05.00045705 Davis, 2003, The role of inflammation in vascular injury and repair, J Thromb Haemost, 1, 1699, 10.1046/j.1538-7836.2003.00292.x Perros, 2007, Dendritic cell recruitment in lesions of human and experimental pulmonary hypertension, Eur Respir J, 29, 462, 10.1183/09031936.00094706 Tamby, 2005, Anti-endothelial cell antibodies in idiopathic and systemic sclerosis associated pulmonary arterial hypertension, Thorax, 60, 765, 10.1136/thx.2004.029082 Tamby, 2006, Antibodies to fibroblasts in idiopathic and scleroderma-associated pulmonary hypertension, Eur Respir J, 28, 799, 10.1183/09031936.06.00152705 Wang, 2009, Impairment of monocyte-derived dendritic cells in idiopathic pulmonary arterial hypertension, J Clin Immunol, 29, 705, 10.1007/s10875-009-9322-8 Heath, 1991, Lung mast cells in plexogenic pulmonary arteriopathy, J Clin Pathol, 44, 1003, 10.1136/jcp.44.12.1003 Miyata, 2000, Athymic nude rats develop severe pulmonary hypertension following monocrotaline administration, Int Arch Allergy Immunol, 121, 246, 10.1159/000024324 Banasova, 2008, Prevention of mast cell degranulation by disodium cromoglycate attenuates the development of hypoxic pulmonary hypertension in rats exposed to chronic hypoxia, Respiration, 76, 102, 10.1159/000121410 Tuder, 1994, Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension, Am J Pathol, 144, 275 Pinto, 2004, Decreased numbers of T-lymphocytes and predominance of recently recruited macrophages in the walls of peripheral pulmonary arteries from 26 patients with pulmonary hypertension secondary to congenital cardiac shunts, Cardiovasc Pathol, 13, 268, 10.1016/j.carpath.2004.06.003 Minamino, 2001, Targeted expression of heme oxygenase-1 prevents the pulmonary inflammatory and vascular responses to hypoxia, Proc Natl Acad Sci USA, 98, 8798, 10.1073/pnas.161272598 Miyata, 1995, Pulmonary hypertension in rats. 1. Role of bromodeoxyuridine-positive mononuclear cells and alveolar macrophages, Int Arch Allergy Immunol, 108, 281, 10.1159/000237165 Itho, 2006, Increased plasma monocyte chemoattractant protein-1 level in idiopathic pulmonary arterial hypertension, Respirology, 11, 158, 10.1111/j.1440-1843.2006.00821.x Ulrich, 2008, Peripheral blood B lymphocytes derived from patients with idiopathic pulmonary arterial hypertension express a different RNA pattern compared with healthy controls: a cross sectional study, Respir Res, 9, 20, 10.1186/1465-9921-9-20 Bonnet, 2007, The nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targeted, Proc Natl Acad Sci USA, 104, 11418, 10.1073/pnas.0610467104 Austin, 2009, T lymphocyte subset abnormalities in the blood and lung in pulmonary arterial hypertension, Respir Med, 104, 454, 10.1016/j.rmed.2009.10.004 Taraseviciene-Stewart, 2007, Absence of T cells confers increased pulmonary arterial hypertension and vascular remodeling, Am J Respir Crit Care Med, 175, 1280, 10.1164/rccm.200608-1189OC Daley, 2008, Pulmonary arterial remodeling induced by a Th2 immune response, J Exp Med, 205, 361, 10.1084/jem.20071008 Ulrich, 2008, Increased regulatory and decreased CD8+ cytotoxic T cells in the blood of patients with idiopathic pulmonary arterial hypertension, Respiration, 75, 272, 10.1159/000111548 Humbert, 1995, Increased interleukin-1 and interleukin-6 serum concentrations in severe pulmonary hypertension, Am J Respir Crit Care Med, 151, 1628, 10.1164/ajrccm.151.5.7735624 Voelkel, 1994, Interleukin-1 receptor antagonist treatment reduces pulmonary hypertension generated in rats by monocrotaline, Am J Respir Cell Mol Biol, 11, 664, 10.1165/ajrcmb.11.6.7946395 Steiner, 2009, Interleukin-6 overexpression induces pulmonary hypertension, Circ Res, 104, 236, 10.1161/CIRCRESAHA.108.182014 Fujita, 2002, Pulmonary hypertension in TNF-a-overexpressing mice is associated with decreased VEGD gene expression, J Appl Physiol, 93, 2162, 10.1152/japplphysiol.00083.2002 Balabanian, 2002, Cx(3)c chemokine fractalkine in pulmonary arterial hypertension, Am J Respir Crit Care Med, 165, 1419, 10.1164/rccm.2106007 Perros, 2007, Fractalkine-induced smooth muscle cell proliferation in pulmonary hypertension, Eur Respir J, 29, 937, 10.1183/09031936.00104706 Dorfmuller, 2002, Chemokine RANTES in severe pulmonary arterial hypertension, Am J Respir Crit Care Med, 165, 534, 10.1164/ajrccm.165.4.2012112 Sanchez, 2007, Role of endothelium-derived CC chemokine ligand 2 in idiopathic pulmonary arterial hypertension, Am J Respir Crit Care Med, 176, 1041, 10.1164/rccm.200610-1559OC Young, 2009, Inhibition of the SDF-1/CXCR4 axis attenuates neonatal hypoxia-induced pulmonary hypertension, Circ Res, 104, 1293, 10.1161/CIRCRESAHA.109.197533 Humbert, 2008, Mediators involved in HIV-related pulmonary arterial hypertension, AIDS, 22, S41, 10.1097/01.aids.0000327515.55041.da Cool, 2003, Expression of human herpesvirus 8 in primary pulmonary hypertension, N Engl J Med, 349, 1113, 10.1056/NEJMoa035115 Henke-Gendo, 2005, Absence of Kaposi's sarcoma-associated herpesvirus in patients with pulmonary arterial hypertension, Am J Respir Crit Care Med, 172, 1581, 10.1164/rccm.200504-546OC Bull, 2008, Human herpesvirus-8 infection of primary pulmonary microvascular endothelial cells, Am J Respir Cell Mol Biol, 39, 706, 10.1165/rcmb.2007-0368OC Moorman, 2005, Hepatitis C virus and the lung: implications for therapy, Chest, 128, 2882, 10.1378/chest.128.4.2882 Robalino, 1991, Association between primary pulmonary hypertension and portal hypertension: analysis of its pathophysiology and clinical, laboratory and hemodynamic manifestations, J Am Coll Cardiol, 17, 492, 10.1016/S0735-1097(10)80121-4 Reiberger, 2010, HIV-HCV co-infected patients with low CD4+ cell nadirs are at risk for faster fibrosis progression and portal hypertension, J Viral Hepatol, 17, 400, 10.1111/j.1365-2893.2009.01197.x Butrous, 2008, Pulmonary vascular disease in the developing world, Circulation, 118, 1758, 10.1161/CIRCULATIONAHA.107.727289 Crosby, 2010, Pulmonary vascular remodeling correlates with lung eggs and cytokines in murine schistosomiasis, Am J Respir Crit Care Med, 181, 279, 10.1164/rccm.200903-0355OC Obeyesekere, 1974, Pulmonary hypertension and filariasis, Br Heart J, 36, 676, 10.1136/hrt.36.7.676 Quarck, 2009, C-reactive protein: a new predictor of adverse outcome in pulmonary arterial hypertension, J Am Coll Cardiol, 53, 1211, 10.1016/j.jacc.2008.12.038 Sanchez, 2006, Immunosuppressive therapy in connective tissue diseases-associated pulmonary arterial hypertension, Chest, 130, 182, 10.1378/chest.130.1.182 Gomberg-Maitland, 2008, Prostacyclin therapies for the treatment of pulmonary arterial hypertension, Eur Respir J, 31, 891, 10.1183/09031936.00097107 Wilkins, 2010, Simvastatin as a treatment for pulmonary hypertension trial (SIPHT), Am J Respir Crit Care Med, 10.1164/rccm.2009111-699OC